Significantly reducing implant loss rates in immediate implant-based breast reconstruction: A protocol and completed audit of quality assurance

Immediate implant-based breast reconstruction (IBR) rates have increased considerably with the advent of acellular dermal matrices. Implant loss is a significant complication and is costly to patients and the NHS. National Mastectomy and Breast Reconstruction Audit and Implant-Based Breast Reconstru...

Full description

Saved in:
Bibliographic Details
Published in:Journal of plastic, reconstructive & aesthetic surgery reconstructive & aesthetic surgery, 2020-06, Vol.73 (6), p.1043-1049
Main Authors: Knight, H.J., Musgrove, J.J., Youssef, M.M.G., Ferguson, D.J., Olsen, S.B., Tillett, R.L.
Format: Article
Language:English
Subjects:
ADM (acellular dermal matrix)
Biological mesh
Implant-based breast reconstruction
Oncoplastic
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immediate implant-based breast reconstruction (IBR) rates have increased considerably with the advent of acellular dermal matrices. Implant loss is a significant complication and is costly to patients and the NHS. National Mastectomy and Breast Reconstruction Audit and Implant-Based Breast Reconstruction Audit data have demonstrated national implant loss rate of 9% at 3 months. National Oncoplastic Guidelines for Best Practice cite a 
ISSN:1748-6815
1878-0539
DOI:10.1016/j.bjps.2019.12.005